• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Cancer Profiling Market – 2018-2023” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current nature and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Cancer Profiling Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Cancer Profiling Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Cancer Profiling Market Size & Forecast

Global Cancer Profiling market witnessed a market value of USD XX Million in 2017 and is estimated to reach USD XX million in 2023, registering a compound annual growth rate (CAGR) of XX% between 2017 and 2023. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Cancer Profiling Market Segmentation

The research offers a comprehensive analysis of global Cancer Profiling market with respect to following sub-markets:

Based on Product Type:
- Instruments
- - - Immunohistochemistry (IHC) Analyzers
- - - Fluorescence In situ Hybridization (FISH) Instruments
- - - PCR instruments
- - - DNA Sequencer
- - - Fragment Analyzer
- Consumables
- - - Reagents & Kits
- - - Other Ancillary (probes, holders etc.)

Based on Indication:
- Breast Cancer
- Colorectal Cancer
- Ovarian Cancer
- Melanoma
- Kidney Cancer
- Lung Cancer (including NSCLC)
- Rare Cancers

Based on End-user:
- Hospitals
- Diagnostic Centres
- Cancer Research Institutes
- Others

Global Cancer Profiling Market: Competitive Landscape

The report also highlights the competitive landscape of the global Cancer Profiling market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Capacity development, research & development and other market activities).

The report includes profiles of leading companies in the global Cancer Profiling market.

Some of the key players profiled include:

- Roche Molecular Systems INC.
- Abbott Laboratories
- Siemens AG
- Neogenomics Laboratories
- Illumina, Inc.
- HTG Molecular Diagnostic
- PerkinElmer Inc.
- Genomic Health INC.
- Nanostring Technologies, Inc.
- BioGenex
- Thermo Fisher Scientific Inc.
- Pacific Biosciences
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2017 – Base Year
- 2018 – Estimated Year
- 2019 to 2023 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Cancer Profiling Industry Report

- What is the overall market size in 2017? What will be the market growth during the forecast period i.e. 2018-2023?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

Research Methodology
Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Cancer Profiling Market
3. Global Cancer Profiling Market Trends
4. Opportunities in Global Cancer Profiling Market
5. Recent Industry Activities, 2017
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Cancer Profiling Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9. Global Cancer Profiling Market Segmentation Analysis, By Product Type
9.1. Introduction
9.2. Market Attractiveness, By Product Type
9.3. BPS Analysis, By Product Type
9.4. Instruments Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1. Immunohistochemistry (IHC) Analyzers
9.4.2. Fluorescence In situ Hybridization (FISH) Instruments
9.4.3. PCR instruments
9.4.4. DNA Sequencer
9.4.5. Fragment Analyzer
9.5. Consumables Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1. Reagents & Kits
9.5.2. Other Ancillary (probes, holders etc.) Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

10. Global Cancer Profiling Market Segmentation Analysis, By Indication
10.1. Introduction
10.2. Market Attractiveness, By Indication
10.3. BPS Analysis, By Indication
10.4. Breast Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.5. Colorectal Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.6. Ovarian Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.7. Melanoma Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.8. Kidney Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.9. Lung Cancer (including NSCLC) Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.10. Rare Cancers Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

11. Global Cancer Profiling Market Segmentation Analysis, By End-user
11.1. Introduction
11.2. Market Attractiveness, By End-user
11.3. BPS Analysis, By End-user
11.4. Hospitals Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.5. Diagnostic Centres Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.6. Cancer Research Institutes Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.7. Others Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

12. Geographical Analysis
12.1. Introduction
12.2. North America Cancer Profiling Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.2.1. By Product Type
12.2.2. By Indication
12.2.3. By End-user
12.2.4. By Country
12.2.4.1. Market Attractiveness, By Indicationr
12.2.4.2. BPS Analysis, By Indicationr
12.2.4.3. U.S. Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.2.4.4. Canada Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

12.3. Europe Cancer Profiling Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.1. By Product Type
12.3.2. By Indication
12.3.3. By End-user
12.3.4. By Country
12.3.4.1. Market Attractiveness, By Country
12.3.4.2. BPS Analysis, By Country
12.3.4.3. Germany Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.4.4. United Kingdom Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.4.5. France Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.4.6. Italy Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.4.7. Spain Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.4.8. Russia Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.3.4.9. Rest of Europe Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

12.4. Asia Pacific Cancer Profiling Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.1. By Product Type
12.4.2. By Indication
12.4.3. By End-user
12.4.4. By Country
12.4.4.1. Market Attractiveness, By Country
12.4.4.2. BPS Analysis, By Country
12.4.4.3. China Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.4. India Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.5. Japan Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.6. South Korea Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.7. Indonesia Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.8. Taiwan Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.9. Australia Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.10. New Zealand Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.4.4.11. Rest of Asia Pacific Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

12.5. Latin America Cancer Profiling Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.5.1. By Product Type
12.5.2. By Indication
12.5.3. By End-user
12.5.4. By Country
12.5.4.1. Market Attractiveness, By Country
12.5.4.2. BPS Analysis, By Country
12.5.4.3. Brazil Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.5.4.4. Mexico Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.5.4.5. Rest of Latin America Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

12.6. Middle East & Africa Cancer Profiling Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.6.1. By Product Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Geography
12.6.4.1. Market Attractiveness, By Geography
12.6.4.2. BPS Analysis, By Geography
12.6.4.3. GCC Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.6.4.4. North Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.6.4.5. South Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.6.4.6. Rest of Middle East & Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

13. Competitive Landscape
13.1. Market Share of Key Players
13.2. Market Positioning of Major Players in Global Cancer Profiling Market
13.3. Company Profiles
13.3.1. Roche Molecular Systems INC.
13.3.1.1. Product Offered
13.3.1.2. Business Strategy
13.3.1.3. Financials
13.3.1.4. SWOT Analysis
13.3.1.5. Market Share Analysis
13.3.1.6. Key Achievements & Developments
13.3.2. Abbott Laboratories
13.3.3. Siemens AG
13.3.4. Neogenomics Laboratories
13.3.5. Illumina, Inc.
13.3.6. HTG Molecular Diagnostic
13.3.7. PerkinElmer Inc.
13.3.8. Genomic Health INC.
13.3.9. Nanostring Technologies, Inc.
13.3.10. BioGenex
13.3.11. Thermo Fisher Scientific Inc.
13.3.12. Pacific Biosciences
13.3.13. Other Major & Niche Key Players

Select License Type
  • Single User License $3375 USD
  • Multi-User License $4275 USD
  • Corporate User License $5175 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients